APPENDIX 1
oscr
Period start date
Month
Year
2024
Period end date
Month
Year
03
2025
Da
01
Da
31
From
To
Office of the Scottish Charity Regulator
Reference and administration details
Charity name
Other names charity is known
by
Registered charity number
Charity's principal address
The Helminth Conference
SC048194
Office 620, Sir Graeme Davies Building
University of Glasgow
120 University Place
Glasgow
G12 8TA
Names of the charity trustees on date of approval of Trustees. Annual Report
Trustee name
Office (if any)
Dates acted if
not for whole year
(or body) entilled to
appoint trustee (if any)
Treasurer
Chair
Twstee
Trustee
10
11
12
13
14
15
16
17
18
19
20

APPENDIX 1
Reference and administration details
Names of all other charity trustees during the period, if any. (for example, those who resigned parl way
through the financial period)
Name
Dates acted rf not for whole
ear
structure, governance and management
Type of governing document
Constitution of 14 February 2018
Trustee recruitment and appointment
All Trustees appointed at registration of Charty 13 March 2018
Objectives and activities
Charitable purposes
The organisation's purposes are..
1 To advance the science of helminth parasitology and the treatment of
the diseases caused by helminth parasites, by promoting international
collaboration and dissemination of information.
2 To advance scientific research into helminth parasitology by convening
conferences, promoting interaction and information exchange be￿een
academics, medical professionals and students from different countries
of the world. and enabling participation of young scientists from lower-
income countries endemic for parasitic diseases
3 To act as a catalyst to advance public understanding and education in
helminth parasitology through publications from conferences and provision
of on-line resources for students, the media and the general public
Summary of the main activities
in relation to these objects
Our principal activity has been the organisation of a Helminth Conference,
as detailed in the Appendix.

APPENDIX 1
Achievements and performance
Summary of the main achievements of
the charity during the financial period
The Charity successfully organised the annual Helminth Conference from
1-6 September 2024. The Conference was attended by nearly 100
researchers from the UK, Europe (Austria, Belgium, France, Germany,
Italy, the Netherlands, Poland, Sweden and Switzerland), Africa
(Cameroon, Ethiopia, Nigeria and Uganda), Asia and Australasia
(Australia, Bangladesh, China and Israel), and the Americas (Canada,
Uruguay and the USA), with a preponderance of younger scientists and
students entering the field. Five delegates (from Cameroon, Ethiopia, India
and Nigeria) were awarded travel bursaries to allow them to participate in
the Conference. The advances in helminth parasitology were presented
and discussed, in furtherance of the Charity's aims. The Conference
included ample provision for ne￿OrkIng be￿een researchers from
different parts of the globe, underpinning new scientific collaborations and
enabling partnerships belmeen experts from drfferent countries.
Financial review
Brief statement of the charity's policy
on reserves
None
Details of any deficit
None
Donated facilities and services (if any)
None

APPENDIX 1
other optional information
Declaration
The trustees declare that they have approved the trustees. report above.
Signed on behalf of the charity's trustees
Signature{s)
Full name(s)
Position (e.g. Chair) Chair
Treasurer
Date
11 July 2025
16 July 2025

APPENDIX 2 

Enter charity name below 

Enter SC No. below 

**The Helminth Conference** 

**SC048194** 

|||**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||Period start date|||||||||Period end date|Period end date||||||||
||**For the period**<br>**from**||01<br>Day||04<br>Month||||2024<br>Year|**to**|Day<br>31||Month<br>03|||||Year<br>**2025**||||
|**Section A Statement of receipts and payments**||||||||||||||||||||||
||**Unrestricted**<br>**funds**||**Restricted**<br>**funds**||||**Expendable**<br>**endowment**<br>**funds**||||**Permanent**<br>**endowment**<br>**funds**||||**Total funds**<br>**current period**|||||**Total funds last**<br>**period**|**Total funds last**<br>**period**|
||**to nearest £**||**to nearest £**||||**to nearest £**||||**to nearest £**||||**to nearest £**|||||**to nearest £**|**to nearest £**|
|**A1 Receipts**||||||||||||||||||||||
|Donations|**9,021**||||||||||||||**9**|**9**|**9**|**9,021**||**4,800**||
|Legacies|||||||||||||||**-**|**-**|**-**|**-**||||
|Grants|||||||||||||||**-**|**-**|**-**|**-**||||
|Receipts from fundraisingactivities|||||||||||||||**-**|**-**|**-**|**-**||||
|Gross tradingreceipts|**44,040**||||||||||||||**44**|**44**|**44**|**44,040**||**105,489**||
|Income from investments other than||||||||||||||||||||||
|land and buildings|**186**||||||||||||||**186**|**186**|**186**|**186**||**147**|**147**|
|Rents from land & buildings|||||||||||||||**-**|**-**|**-**|**-**||||
|Gross receipts from other charitable||||||||||||||||||||||
|activities|||||||||||||||**-**|**-**|**-**|**-**||||
||||||||||||||||**-**|**-**|**-**|**-**||||
|**_A1 Sub total_**|**_A1 Sub total_               53,247**||**-**|**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**53,247**|**53,247**|**53,247**|**53,247**||**110,436**||
|**A2 Receipts from asset &**||||||||||||||||||||||
|**investment sales**||||||||||||||||||||||
|Proceeds from sale of fixed assets<br>**-**<br>Proceeds from sale of investments<br>**-**<br>**_A2 Sub total_                         -**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Total receipts_                53,247**<br>**-**<br>**-**<br>**-**<br>**53,247**<br>**110,436**<br>~~StSt~~||||||||||||||||||||||
|**A3 Payments**||||||||||||||||||||||
|Expenses for fundraising activities|**1,099**||||||||||||||**1**|**1**|**1**|**1,099**||**1,758**||
|Gross trading payments|||||||||||||||**-**|**-**|**-**|**-**||||
|Investment management costs|||||||||||||||**-**|**-**|**-**|**-**||||
|Payments relating directly to||||||||||||||||||||||
|charitable activities|**44,800**||||||||||||||**44**|**44**|**44**|**44,800**||**51,631**||
|Grants and donations|**4,562**||||||||||||||**4**|**4**|**4**|**4,562**||||
|Governance costs:||||||||||||||||||||||
||||||||||||||||**-**|**-**|**-**|**-**||||
|Audit / independent examination|||||||||||||||**-**|**-**|**-**|**-**||||
|Preparation of annual accounts|||||||||||||||**-**|**-**|**-**|**-**||||
|Legal costs|||||||||||||||**-**|**-**|**-**|**-**||||
|Other|Other|||||||||||||||||||||
||||||||||||||||**-**|**-**|**-**|**-**||||
||||||||||||||||**-**|**-**|**-**|**-**||||
|**_A3 Sub total_ **|**50,461**||**-**|**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**50,461**|**50,461**|**50,461**|**50,461**||**53,389**||
|**A4 Payments relating to asset and**||||||||||||||||||||||
|**investment movements**||||||||||||||||||||||
|Purchases of fixed assets<br>**-**<br>Purchase of investments<br>**-**<br>**_A4 Sub total_                          -**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Total payments_                50,461**<br>**-**<br>**-**<br>**-**<br>**50,461**<br>**53,389**<br>~~——————~~||||||||||||||||||||||
|**_Net receipts / (payments)_**<br>**A5 Transfers to / (from) funds**<br>**_Surplus / (deficit) for year_**|**2,786**<br>**-**<br>**-**<br>**-**<br>**-**<br>**57,047**<br>**-**<br>**2,786**<br>**-**<br>**-**<br>**-**<br>**2,786**<br>**57,047**<br>~~SSSSSS~~|||||||||||||||||||||





APPENDIX 2 

**The Helminth Conference** 

**SC048194** 

## **Section B Statement of balances** 

|**Categories**<br>**Signed by one or two trustees**<br>**on behalf of all the trustees**<br>**B1 Cash funds**<br>**B2 Investments**<br>**B3 Other assets**<br>**B5 Contingent liabilities**<br>**B4 Liabilities**|**Details**|**Unrestricted**<br>**funds**<br>**to nearest £**<br>**72,374**<br>**2,786**|**Restricted funds**<br>**to nearest £**|**Expendable**<br>**endowment**<br>**funds**<br>**to nearest £**|**Permanent**<br>**endowment**<br>**funds**<br>**to nearest £**|**Total current**<br>**period**<br>**to nearest £**|**Total last period**<br>**to nearest £**|
|---|---|---|---|---|---|---|---|
||Cash and bank balances at start of year|||||**72,374**|**15,327**|
||Surplus / (deficit) shown on receipts and<br>payments account|||||**2,786**|**57,047**|
|||||||**-**||
|||||||**-**||
||**Cash and bank balances at end of year**<br>(Agree balances with receipts and payments<br>account(s))<br>**Details**|**75,160**|**-**|**-**|**-**|**75,160**|**72,374**|
|||-|<br>-|<br>-<br>**Fund to which**|<br>-<br>**asset belongs**|<br>**Market valuation**<br>**to nearest £**|-<br>**Last year**<br>**to nearest £**|
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
||**Details**||**Fund to which**|**asset belongs**|**Total**<br>**Cost (if available)**<br>**to nearest £**|**-**|<br>**-**|
|||||||**Current value (if**<br>**available)**<br>**to nearest £**|**Last year**<br>**to nearest £**|
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
||**Details**|||**Total**<br>**-**<br>**Fund to which liability relates**|**-**|<br>**-**|<br>**-**|
|||||||**Amount due**<br>**to nearest £**|**Last year**<br>**to nearest £**|
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
||**Details**|||**Total**<br>**Fund to which liability relates**||**-**|**-**|
|||||||**Amount due**<br>**(estimate)**<br>**to nearest £**|**Last year**<br>**to nearest £**|
|||||||||
|||||||||
|||||||||
||**Sinature**|||**Total**<br>**Print Name**||**-**|<br>**-**|
||||||||**Date of**<br>**approval**|
||**g**|||||||
||||||||15.07.2025|
|||||||||



/ Statement of balances 

2 

December 2007 



APPENDIX 2 

**The Helminth Conference** 

**SC048194** 

## **Section C Notes to the Accounts** 

**C1 Nature and purpose of funds** _(may be stated on analysis of funds worksheets)_ 

## **C2 Grants** 

## **C3a Trustee remuneration** 

|**Type of activity or project supported**<br>Travelgrants to low/middle income countryscientists|**Individual /**<br>**institution**<br>**Individuals**|**Number of grants**<br>**made**<br>**£**|**Number of grants**<br>**made**<br>**£**|
|---|---|---|---|
|||**5**|**4,562**|
|||||
|||||
|||||
|||||
|||**Total**|**4,562**<br>|
|||||
|If no remuneration was paid during the period to any charity trustee or person connected to<br>a trustee cross this box (otherwise complete section 3b)|||**x**|
|**Authority under which paid**|||**£**|



## **C3b Trustee remuneration - details** 

## **C4a Trustee expenses** 

If no expenses were paid to any charity trustee during the period then cross this box (otherwise complete section 4b) 

## **C4b Trustee expenses - details** 

## **C5 Transactions with trustees and connected persons** 

|Travel and Accommodation at the Conference<br>**Nature of relationship**<br>**Nature of transaction**|Travel and Accommodation at the Conference<br>**Nature of relationship**<br>**Nature of transaction**|**Number of**<br>**trustees**<br>**£**|**Number of**<br>**trustees**<br>**£**|
|---|---|---|---|
|Travel and Accommodation at the Conference||**3**|**1,803**|
|||||
|||||
|||||
|||||
|**Nature of relationship**||**Transaction**<br>**amount (£)**<br>**Balance**<br>**outstanding at**<br>**period end (£)**||
|||||
|||||
|||||
|||||
|||||



## **C6 Other information** 

/ Notes 

3 

December 2007 



APPENDIX2
l Not8S
Dec8mber 2007

APPENDIX 2 

**The Helminth Conference** 

**SC048194** 

## **Additional analysis (1)** 

## **Analysis of receipts and payments** 

## **1 Donations** 

|**1 Donations**|||||||||
|---|---|---|---|---|---|---|---|---|
||**Unrestricted**<br>**funds**<br>**to nearest £**<br>**4,290**<br>**4,000**<br>**731**||**Restricted funds**<br>**to nearest £**|**Expendable**<br>**endowment**<br>**funds**<br>**to nearest £**|**Permanent**<br>**endowment**<br>**funds**<br>**to nearest £**|**Total current**<br>**period**<br>**to nearest £**<br>**4,290**<br>**4,000**<br>**731**<br>**-**||**Total last**<br>**period**<br>**to nearest £**|
|Merck|**4,290**|||||**4,290**||**4,300**|
|New England Biolabs|**4,000**|||||**4,000**|||
|Frontiers Publishers|**731**|||||**731**|||
|**eLife Publisher**||||||**-**||**500**|
|**Total**|**9,021**||**-**|**-**|**-**|**9,021**||**4,800**|
||**-**||**-**|**-**|**-**|**-**||**-**|



## **2 Grants** 

|**2 Grants**|||||||||
|---|---|---|---|---|---|---|---|---|
||**Unrestricted**<br>**funds**<br>**to nearest £**||**Restricted funds**<br>**to nearest £**|||**Total current**<br>**period**<br>**to nearest £**||**Total last**<br>**period**<br>**to nearest £**|
|Travel grants to sceintists from low income countries|**4,562**|||||**4,562**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|**Total**<br>**4,562**<br>**reference**<br>**Unrestricted**<br>**funds**<br>**to nearest £**<br>**3  Gross receipts from other charitable activities**|**4,562**||**-**|||**4,562**||**-**|
||||**-**<br>**Restricted funds**<br>**to nearest £**|**Expendable**<br>**endowment**<br>**funds**<br>**to nearest £**|**Permanent**<br>**endowment**<br>**funds**<br>**to nearest £**|**reference**<br>**Total current**<br>**period**<br>**to nearest £**||**-**<br>**Total last**<br>**period**<br>**to nearest £**|
|Delegate fees for conference|**44,040**|||||**44,040**||**50,889**|
|Delegate fees for 2023 received in 2024||||||**-**||**54,600**|
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|**Total**|**44,040**||**-**|**-**|**-**|**44,040**||**105,489**|
||reference error||-|-|-|reference error||reference error|



## **4  Payments relating directly to charitable activities** 

||**Unrestricted**<br>**funds**<br>**to nearest £**|**Unrestricted**<br>**funds**<br>**to nearest £**|**Restricted funds**<br>**to nearest £**|**Expendable**<br>**endowment**<br>**funds**<br>**to nearest £**|**Permanent**<br>**endowment**<br>**funds**<br>**to nearest £**|**Total current**<br>**period**<br>**to nearest £**|**Total current**<br>**period**<br>**to nearest £**|**Total last**<br>**period**<br>**to nearest £**|
|---|---|---|---|---|---|---|---|---|
|Venue, accommodation, meals and sundry items|**37,570**|<br>||||**37,570**||**37,969**|
|Travel costs of invited speakers and organisers|**7,230**|||||**7,230**|<br> <br> <br> <br> <br> <br> <br> <br> <br>|**13,622**|
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|||||||**-**|||
|**Total**|**44,800**||**-**|**-**|**-**|**44,800**||**51,591**|
||-||-|-|-|-||reference error|



Additional notes (1) 

December 2007 



APPENDIX 2 

**SC048194** 

## **Additional analysis (2)** 

## **5  Breakdown of unrestricted funds** 

|**5  Breakdown of unrestricted funds**||||||||
|---|---|---|---|---|---|---|---|
|**Receipts**|**Unrestricted**<br>**fund 1 - enter**<br>**name of fund**<br>**below**||**Unrestricted**<br>**fund 2 - enter**<br>**name of fund**<br>**below**|**Unrestricted**<br>**fund 3 - enter**<br>**name of fund**<br>**below**|**Unrestricted**<br>**fund 4 - enter**<br>**name of fund**<br>**below**|**Total**<br>**unrestricted**<br>**funds**|**Total**<br>**unrestricted**<br>**funds last**<br>**period**|
|Donations|**9,021**|||||**9,021**|**4,800**|
|Legacies||||||**-**||
|Grants||||||**-**||
|Receipts from fundraisingactivities|**44,040**|||||**44,040**|**105,489**|
|Gross tradingreceipts||||||**-**||
|Income from investments other than land and buildings|**186**|||||**186**|**147**|
|Rents from land & buildings||||||**-**||
|Gross receipts from other charitable activities||||||**-**||
|**_Sub total_**<br>**Receipts from asset & investment sales**|**53,247**||**-**|**-**|**-**|**53,247**|**110,436**|
|||||||-||
|Proceeds from sale of fixed assets||||||**-**||
|Proceeds from sale of investments||||||**-**||
|**_Sub total_**<br>**_Total receipts_**<br>**Payments**|**-**||**-**|**-**|**-**|**-**|**-**|
||**53,247**||**-**|**-**|**-**|**53,247**|**110,436**|
|||||||-||
|Expenses for fundraisingactivities|**1,099**|||||**1,099**|**1,758**|
|Gross tradingpayments||||||**-**||
|Investment management costs||||||**-**||
|Payments relatingdirectlyto charitable activities|**44,800**|||||**44,800**|**51,631**|
|Grants and donations|**4,562**|||||**4,562**||
|Governance costs:||||||**-**||
|Audit / independent examination||||||**-**||
|Preparation of annual accounts||||||**-**||
|Legal costs||||||**-**||
|||||||**-**||
|||||||**-**||
|**_Sub total_**<br>**Payments relating to asset and investment**<br>**movements**|**50,461**||**-**|**-**|**-**|**50,461**|**53,389**|
|||||||-||
|Purchases of fixed assets||||||**-**||
|Purchase of investments||||||**-**||
|**_Sub total_**<br>**_Total payments_**<br>**_Net receipts / (payments)_**<br>**Transfers to / (from) funds**<br>**_Surplus / (deficit) for year_**|**-**||**-**|**-**|**-**|**-**|**-**|
|||||||-||
||**50,461**||**-**|**-**|**-**|**50,461**|**53,389**|
|||||||-||
||**2,786**||**-**|**-**|**-**|**2,786**|**57,047**|
|||||||||
|||||||**-**||
|||||||||
||**2,786**||**-**|**-**|**-**|**2,786**|**57,047**|
|||||||-||



**Nature and purpose of funds** 

Additional notes (2) 

December  2007 



APPENDIX 3
OSCR
kollsh o￿nty Regulator
Independent examiner's report on the accounts
Report to the The Helminth Conference
trusteeslmembeTS of
Registèred charity SC048194
number
On the accounts ofthe
Charity for the period
Period start date
Morth
Period end date
Month
Y•ar
Y8ar
01
2(r24
to
03
2025
Set out on pages
nL¥nbern cl atthl¥yW sheeis)
Respe¢tlvo The charity's trustees are responsible for the weparation of the accounts in accordance
responslbilities of with the temis of the Charities Trustee Investrnent {Scotland) 2005 Act and the
trustow4 and examiner
Charities Accounts (SCO￿and) Regulations 2006. The charity trustees consider that the
audit requirernent of RegulatL>n 10(1) (d} of the Accounts Regulations does not apply. It
is my responsibilty to Èxamine the accounts as required under sects.on 44(1) (c) of the
Act and to stale whether particular matters have come to my attention.
Basis of independent My examination is carried out in arxofdance with Regulation 11 of the Charities
examinerfs statement Accounts {Scottandl Regulations 2006. An examination includes a review of the
accounting records kept by the charity and a ct)mparison of the accounts presented w.rth
those records. It also includes considerats.on of any unusual items or disclosures in Ihe
ac£ounts and seeks explana170ns from the tTUStees conceming any such matters. The
procedures undertaken do not provide all the evidence that would be required in an audit
and, consequently, I do not exwess an audit opinion on the accounts.
Independent exarninerfs In the course of my examinats'on, no matter has come to ry attentl'on [other than that
statement disclosed on the attached page1
which gives me reasonable cause to believe that in any material respect Ihe
requirements:
to keep accounts'ng re￿￿S In a￿)rdance with seGlion 44(1) (a) of the 2005 Act and
Regulation 4 of the 2006 ￿Unts Regulations, and
to prepare accounts wh￿h accord with the accounting records and comply with
Regulati(￿ 9 of the 2006 Accounts Regulations
have not been rrE( or
to which, in my opinion. attention should be drawn in order to enable a proper
i indar¢t?ndinti of thp. acrJ)vnts to bg. reached
Slgned:
Name;
Relevant professional
qualificatlon(s) or body
(il any):
Addres8:
as8 delete the words in the brnc
folknvry page.